Answers are grounded in this paper and cite their sources.
Background: This study aimed to measure the levels of IL-1β, IL-18, and IFN-Ƴ in the sera of patients with severe COVID-19 in Diyala province in Iraq. Materials & Methods: Blood samples were collected from 60 patients in Baquba Teaching Hospital in Iraq between January and April 2021, these patients had clinical signs and symptoms of COVID-19, diagnosed by the hospital doctors; in addition, 30 samples were taken from healthy control people, and the levels of IL_1β, IL_18, and IFN_Ƴ markers were detected in COVID-19 patients and the control group by ELISA (enzyme-linked immunosorbent assay) technique. Findings: This study displayed the high level of IL_1β, IL_18, and IFN_Ƴ in COVID-19 patients compared with the control group (154.04 ± 16.54 versus 85.41 ± 8.9 pg/mL, 82.88 ± 7.96 versus 66.67 ± 9.34 pg/mL, and 116.06 ± 26.5 versus 97.96 ± 12.2pg/mL, respectively). This study also showed a high prevalence of COVID-19 in males compared to females. In the sera of COVID-19 patients, the levels of IL_1β, IL_18, and IFN_Ƴ were noticeably higher in females than in males. Conclusion: There was a significant difference in the levels of IL_1β, IL_18, and IFN-Ƴ between the study groups; also, they were higher in females than in males.
No takes yet. Share an insight, caveat, or question.
Shahrazad Ahmed Khalaf (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: